Posts Tagged 'gsk'

Foreign Investigators Linked to GlaxoSmithKline Indicted

Chinese prosecutors have indicted a foreign couple for the illegal collection of personal information by their private firm on behalf of drugmaker GalxoSmithKline last year. This is the first indictment announced by Chinese prosecutors of foreigners conducting an illegal investigation.

The couple, a 58 year old U.K. man and a 61 year old U.S. citizen, were indicted for illegally tracking personal information that had been obtained through hidden photography and “infiltration.” The data that was collected includes ...

continue reading...

GlaxoSmithKline to Pay $105 Million Settlement

GlaxoSmithKline paying 105 million dollar fine over false marketing claimsGlaxoSmithKline, a London-based pharmaceutical company, agreed to pay a $105 million settlement to 44 states and the District of Columbia. The company was allegedly unlawfully marketing Advair, its asthma drug, and two popular antidepressants.

The lawsuits claimed that GlaxoSmithKline was using off-label marketing and violated state consumer protection laws. Off-label marketing is when a company markets a drug for uses that are not approved by the ...

continue reading...

GlaxoSmithKline Comes Under Investigation for Corruption by Chinese Officials

According to the website of China’s Ministry of Public Security, executives of GlaxoSmithKline’s operations in China confessed to charges of bribery and tax law violations. The Ministry detailed more than $489 million worth of bribes to government officials, medical associations, hospitals, and doctors to boost sales and prices. China’s official newspaper, the People’s Daily, and the Xinhua news agency both reported that Glaxo collaborated with more than 700 travel agencies and consultancies over a six year span to bribe doctors ...

continue reading...

GSK Cancer Vaccine Falls Short in Trial

A new cancer vaccine has failed its primary-stage development trials. A story by MedPage Today reports that GlaxoSmithKline PLC (“GSK”) has announced its experimental cancer vaccine MAGE-A3 has failed to meet requirements to slow progressions to advanced stages of Melanoma.

This is a huge setback for the pharmaceutical giant. GSK claims the drug did not meet a primary goal in a late-stage trial in patients with melanoma, which was hoped to significantly extend the disease-free life of patients ...

continue reading...
Page 2 of 2 12